BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 26920025)

  • 1. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
    Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
    Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.
    Longoni N; Sarti M; Albino D; Civenni G; Malek A; Ortelli E; Pinton S; Mello-Grand M; Ostano P; D'Ambrosio G; Sessa F; Garcia-Escudero R; Thalmann GN; Chiorino G; Catapano CV; Carbone GM
    Cancer Res; 2013 Jul; 73(14):4533-47. PubMed ID: 23687337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-specific ETS-1 (ESE1/ELF3) regulates apoptosis of intestinal epithelial cells in ulcerative colitis via accelerating NF-κB activation.
    Li L; Miao X; Ni R; Miao X; Wang L; Gu X; Yan L; Tang Q; Zhang D
    Immunol Res; 2015 Jun; 62(2):198-212. PubMed ID: 25926267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of mouse Elf3 C-terminal DNA-binding domain in complex with type II TGF-beta receptor promoter DNA.
    Agarkar VB; Babayeva ND; Wilder PJ; Rizzino A; Tahirov TH
    J Mol Biol; 2010 Mar; 397(1):278-89. PubMed ID: 20079749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity.
    Otero M; Peng H; Hachem KE; Culley KL; Wondimu EB; Quinn J; Asahara H; Tsuchimochi K; Hashimoto K; Goldring MB
    Connect Tissue Res; 2017 Jan; 58(1):15-26. PubMed ID: 27310669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
    Keeton EK; Brown M
    Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
    Singh K; Munuganti RS; Leblanc E; Lin YL; Leung E; Lallous N; Butler M; Cherkasov A; Rennie PS
    Breast Cancer Res; 2015 Feb; 17(1):27. PubMed ID: 25848700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.
    Johnsen SA; Güngör C; Prenzel T; Riethdorf S; Riethdorf L; Taniguchi-Ishigaki N; Rau T; Tursun B; Furlow JD; Sauter G; Scheffner M; Pantel K; Gannon F; Bach I
    Cancer Res; 2009 Jan; 69(1):128-36. PubMed ID: 19117995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELF3 is a repressor of androgen receptor action in prostate cancer cells.
    Shatnawi A; Norris JD; Chaveroux C; Jasper JS; Sherk AB; McDonnell DP; Giguère V
    Oncogene; 2014 Feb; 33(7):862-71. PubMed ID: 23435425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
    Band AM; Laiho M
    Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
    Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
    Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.
    Schultz DJ; Wickramasinghe NS; Ivanova MM; Isaacs SM; Dougherty SM; Imbert-Fernandez Y; Cunningham AR; Chen C; Klinge CM
    Mol Cancer Ther; 2010 Mar; 9(3):594-605. PubMed ID: 20197399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells.
    Kanaujiya JK; Lochab S; Kapoor I; Pal P; Datta D; Bhatt ML; Sanyal S; Behre G; Trivedi AK
    Proteomics; 2013 Jul; 13(14):2100-12. PubMed ID: 23576398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different domains of the transcription factor ELF3 are required in a promoter-specific manner and multiple domains control its binding to DNA.
    Kopp JL; Wilder PJ; Desler M; Kinarsky L; Rizzino A
    J Biol Chem; 2007 Feb; 282(5):3027-41. PubMed ID: 17148437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
    Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.
    Karmakar S; Jin Y; Nagaich AK
    J Biol Chem; 2013 Aug; 288(33):24020-34. PubMed ID: 23814048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.